Phibro Animal Health (PAHC) Net Income towards Common Stockholders (2012 - 2026)

Phibro Animal Health's Net Income towards Common Stockholders history runs 15 years deep, the most recent figure standing at $24.0 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders rose 15.06% year-over-year to $24.0 million; the TTM figure through Mar 2026 stood at $95.2 million (up 783.22% YoY), while the FY2025 annual figure was $48.3 million, up 211.43% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at $24.0 million, down from $27.5 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $27.5 million in Q4 2025, with the low at -$45.0 million in Q2 2024.
• The 5-year median for Net Income towards Common Stockholders is $8.4 million (2024), against an average of $8.3 million.
• The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders slumped 491.19% in 2024, then surged 762.14% in 2025.
• Phibro Animal Health's Net Income towards Common Stockholders stood at $7.2 million in 2022, then slumped by 82.33% to $1.3 million in 2023, then soared by 150.0% to $3.2 million in 2024, then surged by 762.14% to $27.5 million in 2025, then declined by 12.51% to $24.0 million in 2026.
• Business Quant data shows PAHC's Net Income towards Common Stockholders at $24.0 million in Q1 2026, $27.5 million in Q4 2025, and $26.5 million in Q3 2025.